Interferon beta-1a is a drug in the interferon family used to treat multiple sclerosis. It is the pioneering treatment for multiple sclerosis with, as of 2005, 16 years of data demonstrating its safety and efficacy. While these drugs improve certain diagnostic test results, many patients report no perceived improvement, along with serious side-effects that substantially reduce quality of life. ...